Phase 1 study of intraventricular

HIGHLIGHTS

• who: Kim Kramer from the Departments of Pediatrics, Memorial Sloan Kettering Cancer Center, York Box, New York, NY, USA have published the research: Phase 1 study of intraventricular, in the Journal: (JOURNAL)
• what: An investigator-initiated, single-arm, single-center, phase I trial with a standard 3 + 3 dose escalation and expansion cohort design (NCT00089245) , the primary objective of which was to study the toxicity and to establish the recommended phase II dose for 131I-omburtamab, was performed.
• how: The authors conducted a phase I trial of intraventricular using a standard 3 + 3 . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.